产品编号: DC7229 Featured
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
PF-4708671 is a novel cell-permeable inhibitor of S6K1 (p70 ribosomal S6 kinase 1), with a Ki of 20 nM and IC50 of 160 nM.
Cas No.: 1255517-76-0
名称: 1H-Benzimidazole,2-[[4-(5-ethyl-4-pyrimidinyl)-1-piperazinyl]methyl]-6-(trifluoromethyl)-
别名: PF 4708671; PF4708671
分子式: C19H21F3N6
分子量: 390.410
纯度: >98%
保存条件: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
Description: PF-4708671 is a piperazinyl-pyrimidine analogue and the first S6K1-specific inhibitor. PF-4708671 does not significantly inhibit the activity of the closely related S6K2 iso Form or a number of other AGC kinases (Akt1, Akt2, PKA, PKCα, PKCϵ, PRK2, ROCK2, RSK1, RSK2 or SGK1) . PF-4708671 prevents the S6K1-mediated phosphorylation of S6 protein in response to IGF-1 (insulin-like growth factor 1), while having no effect upon the PMA-induced phosphorylation of substrates of the highly related RSK (p90 ribosomal S6 kinase) and MSK (mitogen- and stress-activated kinase) kinases. PF-4708671 is also found to induce phosphorylation of the T-loop and hydrophobic motif of S6K1, an effect that is dependent upon mTORC1 (mTOR complex 1). PF-4708671 does not affect activity of mTORC1.For the detailed information of PF-4708671, the solubility of PF-4708671 in water, the solubility of PF-4708671 in DMSO, the solubility of PF-4708671 in PBS buffer, the animal experiment (test) of PF-4708671, the cell expriment (test) of PF-4708671, the in vivo, in vitro and clinical trial test of PF-4708671, the EC50, IC50,and Affinity of PF-4708671, Please contact DC Chemicals.
In Vivo:
In Vitro:
Kinase Assay:
Cell Assay:
Animal Administration:
产品编号 产品名称 应用领域
DC20000 LR-90 LR-90 is an advanced glycation end product (AGE) inhibitor, inhibits inflammatory responses in human monocytes. LR-90 is also used in the research of diabetic animal model.
DC26231 Furin Inhibitor II Hexa-D-arginine (Furin Inhibitor II) 是一种稳定的 furin 抑制剂,对 furin,PACE4 和 PC1 的 Ki 值分别为 106 nM,580 nM 和 13.2 μM。Hexa-D-arginine 在体外和体内均可阻断假单胞菌外毒素 A 和炭疽毒素的毒性。
DC21672 SNAP-94847 hydrochloride SNAP 94847 是一种新型的,高亲和力的选择性黑色素浓缩激素受体 1 (MCHR1) 拮抗剂,其 (Ki= 2.2 nM, Kd=530 pM),它对 MCHα1A 和 MCHD2 受体分别显示出 >80 倍和 >500 倍的选择性。 SNAP 94847 以高亲和力与小鼠和大鼠 MCHR1 结合,与其他 GPCR,离子通道,酶和转运蛋白的交叉反应性很小。
DC8759 Thiamet G Thiamet G is a potent and selective inhibitor of O-GlcNAcase that demonstrates a Ki value of 21 nM.
DC9619 Nafamostat (mesylate) Nafamostat mesylate, a synthetic serine protease inhibitor, is an anticoagulant,showed highly potent activity against COVID-19(SARS-COV-2).
DC8729 Bifeprunox Dopamine D2 and 5-HT1A partial agonist in development as a potential treatment for schizophrenia and other psychotic indications; Pharmacoloy profile makes it an atypical antipsychotic and a new approach for the treatment of schizophrenia.
DC7992 PX 12 PX-12(IV-2) is an irreversible inhibitor of Thioredoxin-1(Trx-1) currently in clinical development as an antitumor agent; IC50=7 uM in Hela, MTT assay, 72 h.
DC7773 BNC-105 BNC105 is a novel tubulin polymerization inhibitor that selectively disrupts tumor vasculature and displays single-agent antitumor efficacy.
DC7229 PF-4708671 PF-4708671 is a novel cell-permeable inhibitor of S6K1 (p70 ribosomal S6 kinase 1), with a Ki of 20 nM and IC50 of 160 nM.
DC28714 FK962 FK962 is an enhancer of somatostatin release, exerts cognitive-enhancing actions. Anti-dementia properties.